Device

Part:BBa_K4062025

Designed by: Benjamin Bateman   Group: iGEM21_WLC-Milwaukee   (2021-10-16)


lactose regulated bla, CAP mutation

This device regulates the expression of b-lactamase using environmental lactose concentration and the regulatory components of the lac operon. The lacI biobrick has a mutation in the CAP binding site that deletes the first five bases. This mutation has been shown to significantly reduce the binding of the CAP protein to the CAP site [1]. The mutation was verified by sequencing.

Additionally, the mutation was observed by a lack of color change in an environment with high lactose concentration and low glucose concentration (pictured). Ideally, the high lactose/low glucose culture would elicit a greater color change, since the lac repressor should not be bound to lacO.

T--WLC-Milwaukee--cap1.png


Using more concentrated nitrocefin (chromogenic substrate of b-lactamase) and adding a simultaneous glucose/lactose exposure showed results closer to what was expected (pictured). However, these are subjective and need quantification.


T--WLC-Milwaukee--cap3.png


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 2914
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 1982


[edit]
Categories
Parameters
None